Collaboration Shines as BIO Asia–Taiwan 2023 Concludes

Event co-organizer the Taiwan Bio Industry Organization (Taiwan BIO), stated that international participation was notably higher this year due to the lifti...

August 02, 2023 | Wednesday | News
Australia: First Patient Dosed in Chemotherapy-Free Soft Tissue Sarcoma Trial.

Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a clinical-stage biotechnology company developing novel LAG-3 immu...

July 31, 2023 | Monday | News
South Korea's PharmAbcine Initiates Phase I Trial of Novel TIE2 Antibody in nAMD"

The study, consisting of single ascending-dose cohort and multiple ascending-dose cohort, has dosed the first of 36 planned study subjects. The Phase I cli...

July 27, 2023 | Thursday | News
Samsung Biologics releases 2023 ESG Report, reaffirming its commitment to net-zero progress and corporate social responsibility

“Samsung Biologics is fully committed to engaging in sustainable business practices for the positive impact it has on our clients, society, and the w...

July 18, 2023 | Tuesday | News
Japan's ThinkCyte & FIMM Forge Research Partnership to Fight Blood Cancer

"Blood cancers are a complex, heterogeneous set of diseases and while the treatment landscape has advanced in recent years, there is still a lot we don't k...

July 18, 2023 | Tuesday | News
Examining the Biopharma Industry's Declining Resilience: Factors, Vulnerabilities, and Strategies for Growth

Join us for an in-depth conversation with Chua Keng Hock as we explore the challenges, strategies, and future prospects of the biopharma industry in today'...

July 18, 2023 | Tuesday | Interaction
Avantor® Inaugurates Expanded Singapore Hub

Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies, a...

July 13, 2023 | Thursday | News
HUTCHMED Begins Phase I Study of Novel SHP2 Inhibitor for Advanced Solid Tumors in China

The clinical trial is a multi-center, open-label study to evaluate the safety, tolerability, pharmacokinetics and preliminary efficacy profile of HMPL-415 ...

July 10, 2023 | Monday | News
INOVIQ and Promega announce global marketing agreement for EXO-NET exosome solutions

INOVIQ and Promega sign a global joint marketing agreement for INOVIQ’s EXO-NET® exosome capture technology and Promega Nucleic Acid purificati...

July 07, 2023 | Friday | News
FDA grants traditional approval for LEQEMBI® for Alzheimer's treatment

The Centers for Medicare & Medicaid Services (CMS) announced broader Medicare coverage of LEQEMBI Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Nai...

July 07, 2023 | Friday | News
Samsung Bioepis Releases 2023 Sustainability Report

Reaffirms commitment to environmentally and socially responsible practices in R&D, clinical trials, manufacturing, and supply chain management to ena...

June 30, 2023 | Friday | News
WuXi Biologics Announced Global Strategic Partnership with Pharmadule Morimatsu at its Singapore CRDMO Center Project

Under the partnership, Pharmadule Morimatsu will provide modular facilities for the WuXi Biologics Singapore CRDMO Center project.   This strategic ...

June 29, 2023 | Thursday | News
Bayer initiates Phase III studies with investigational contrast agent gadoquatrane

Gadoquatrane is a highly stable contrast agent for magnetic resonance imaging (MRI) with high relaxivity and the potential of a substantially lower gadol...

June 28, 2023 | Wednesday | News
Kalos Medical's DENEX Hypertension Treatment System Earns Korean MFDS Innovative Medical Device Designation

The DENEX system is an innovative medical device that treats hypertension using minimally invasive renal denervation technology. Electrodes are inserted in...

June 28, 2023 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close